|Bid||256.86 x 900|
|Ask||256.87 x 900|
|Day's Range||255.87 - 259.23|
|52 Week Range||225.65 - 355.88|
|Beta (3Y Monthly)||1.00|
|PE Ratio (TTM)||20.11|
|Earnings Date||Jul 30, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||2.20 (0.85%)|
|1y Target Est||319.19|
As we head into the 2020 election campaign, health care is a top area of interest for voters. In 2019, Americans spent $3.65 trillion dollars. EmblemHealth CEO, Karen Ignagni, joins Yahoo Finance to explain what she thinks needs to be done to lower the cost.
FedEx is under pressure as China is launching an investigation into the delivery giant. The investigation comes after FedEx diverted packages sent from Chinese tech giant Huawei. China claims the diversions are related to the ongoing trade tensions with the U.S. Yahoo Finance's Ines Ferre breaks down how the stock is moving, along with other names seeing pressure in early trading Monday.
Delphi panel finds distinct differences in the way common terms are understood by health care professionals, illustrating the complexity of concepts integral to health care transfo
“Medicare for All” got a hearing Wednesday before a powerful House panel, but there continued to be signs that top Democrats aren’t embracing the issue.
Humana Inc. (HUM), a leading health and well-being company, and Epic, the most widely-used comprehensive health record system, today announced an agreement that will integrate technologies to enhance patient, provider and payer access to health information. Humana is the first national healthcare insurer to collaborate with Epic to bring together patients, providers, and payers to power value-based care. Humana and Epic are advancing interoperability to promote open communication and information transparency that will give patients and their practitioners integrated and real-time access to the patients’ medical history, health insights and treatment options, which, in turn, enables cost reduction, improves quality and increases patient satisfaction.
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]
Humana Inc NYSE:HUMView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for HUM with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting HUM. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding HUM totaled $5.41 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. HUM credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Is Humana Inc. (NYSE:HUM) a good dividend stock? How would you know? Dividend paying companies with growing earnings...
Humana Inc. announced today that Brian A. Kane, Chief Financial Officer, will make a presentation to investors at the Goldman Sachs Healthcare Conference on Wednesday, June 12, 2019, at 10:40 a.m.
Stocks that moved substantially or traded heavily on Monday: Cypress Semiconductor Corp., up $4.25 to $22.07 German chipmaker Infineon is buying the company for more than $10 billion in cash. Centene Corp., ...
The three major U.S. stock indexes declined on Monday on weaker-than-expected economic data, while shares of Alphabet, Facebook and Amazon.com fell sharply on fears the companies are the targets of U.S. government antitrust regulators, putting pressure on the tech-laden Nasdaq. The benchmark S&P 500 swung in and out of negative territory as investors also eyed the latest comments around the U.S. trade battles with both China and Mexico as well as U.S. President Donald Trump's decision Friday to end preferential trade treatment for India.
Is a Centene-Humana deal in the works?Source: Shutterstock Recent rumors claiming that a Centene-Humana deal is in the works have been shot down. The killing of this rumor comes directly from Humana (NYSE:HUM), which says it has no plans of taking over Centene (NYSE:CNC).The official statement from Humana rejecting the idea of a Centene-Humana deal comes in the form of a filing with the U.S. Securities and Exchange Commission. The company has this to say in its filing.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"Humana Inc.'s (the "Company") long-standing policy is not to comment on rumors or speculation regarding possible M&A activity. However, in light of the significant investor speculation and persistent market rumors regarding the Company's intentions with respect to pursuing a combination with Centene Corporation ("Centene"), the Company has chosen to make a one-time, limited exception to its no-comment policy (which continues in effect) and confirm that the Company will not make a proposal to combine with Centene as an alternative to Centene's proposed transaction with WellCare Health Plans, Inc. The Company does not intend to make any further statement regarding the foregoing." * 7 Bank Stocks to Leave in the Vault It doesn't get much more clear than that. Now that the rumors of a Centene-Humana deal are dead, CNC stock is taking a beating.CNC stock was down 9% and HUM stock was up 1% as of noon Monday. CNC stock is up 2% and HUM stock is down 13% since the start of the year. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Heavily Shorted Stocks to Sell -- Because the Bears Are Right * 7 Bank Stocks to Leave in the Vault * 7 Stocks for You to Profit From (Legal) Insider Trading As of this writing, William White did not hold a position in any of the aforementioned securities.Compare Brokers The post Centene-Humana Deal? Nope. CNC Stock Slides on the News appeared first on InvestorPlace.
U.S. stocks slipped on Monday as internet giants Alphabet and Amazon tumbled on regulatory concerns, but hopes that the United States would settle its dispute with Mexico helped limit some losses. Alphabet Inc declined 6.4% after sources told Reuters said the U.S. Justice Department is preparing an investigation of the Google-parent to determine whether the company broke antitrust laws in operating its online businesses.
Centene shares are tumbling after Humana took the rare step of publicly refuting reports that it's interested in buying the company. Centene Corp., based in St. Louis, is in the midst of a $15 billion takeover of WellCare, another insurer specializing in government funded health coverage. Humana said in a prepared statement Monday that it will not make a bid for Centene, which specializes in running state-based Medicaid coverage programs.
An unusual SEC filing by health-insurance provider Humana was sending shares of rival health insurance company Centene tumbling.
Humana said in a regulatory filing Monday that it has no designs on Centene, following a push for a combination from activist investors that opposed the WellCare deal. Centene shares fell 7.5% to $53.43 at 9:39 a.m. in New York. Humana gained 5.2% to $257.63.
Shares of health insurer Centene were down sharply Monday after rival Humana said that it would not place a bid for the company. Humana shares were rising 3.9% in trading. "Humana Inc.'s long-standing policy is not to comment on rumors or speculation regarding possible M&A activity.
Humana Inc said on Monday it would not bid for Centene Corp, quelling speculation that it would acquire the health insurer that has already agreed to buy smaller rival WellCare Health Plans Inc for $15.27 billion. Centene shares fell 6.9% to $53.75 before the bell, while Humana rose 2% to $250. WellCare shares remained unchanged.
Employees of Humana Inc. (HUM) have made tremendous strides in their health and well-being in recent months including achieving the first ever Associate Bold Goal of gaining 20% improvement in Healthy Days. These strides have been captured in the Humana Well-being: 2018 Annual Report, released for the first time publicly here. Compiled for the seventh time, this web-based, interactive report features rich data and personal video stories from several Humana employees, aka associates.
Centene or Humana: Which Is a Better Pick in May?(Continued from Prior Part)Group & Specialty segmentIn its first-quarter earnings press release, Humana (HUM) guided for Group & Specialty segment earnings of $300 million–$350 million. The